Surprising CPAP Findings Should Not Discourage Development – NEJM
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers should continue to develop continuous positive airway pressure technology to improve cardiovascular outcomes, despite a new trial showing that the procedure does not improve mortality in heart failure patients with central sleep apnea, according to an editorial in the Nov. 10 New England Journal of Medicine.